Bayesian Capital Management »

Mersana Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $28k 12k 2.32
2023-03-31 $102k 25k 4.11